1. Home
  2. INVX vs PRTA Comparison

INVX vs PRTA Comparison

Compare INVX & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVX
  • PRTA
  • Stock Information
  • Founded
  • INVX 2024
  • PRTA 2012
  • Country
  • INVX United States
  • PRTA Ireland
  • Employees
  • INVX N/A
  • PRTA N/A
  • Industry
  • INVX
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVX
  • PRTA Health Care
  • Exchange
  • INVX NYSE
  • PRTA Nasdaq
  • Market Cap
  • INVX 954.4M
  • PRTA 809.8M
  • IPO Year
  • INVX N/A
  • PRTA N/A
  • Fundamental
  • Price
  • INVX $18.38
  • PRTA $11.74
  • Analyst Decision
  • INVX Sell
  • PRTA Buy
  • Analyst Count
  • INVX 1
  • PRTA 9
  • Target Price
  • INVX $16.00
  • PRTA $54.57
  • AVG Volume (30 Days)
  • INVX 308.5K
  • PRTA 457.6K
  • Earning Date
  • INVX 05-11-2025
  • PRTA 05-07-2025
  • Dividend Yield
  • INVX N/A
  • PRTA N/A
  • EPS Growth
  • INVX 20.96
  • PRTA N/A
  • EPS
  • INVX 2.77
  • PRTA N/A
  • Revenue
  • INVX $660,803,000.00
  • PRTA $135,157,000.00
  • Revenue This Year
  • INVX N/A
  • PRTA N/A
  • Revenue Next Year
  • INVX $6.15
  • PRTA $131.75
  • P/E Ratio
  • INVX $6.64
  • PRTA N/A
  • Revenue Growth
  • INVX 18.95
  • PRTA 47.92
  • 52 Week Low
  • INVX $12.54
  • PRTA $11.42
  • 52 Week High
  • INVX $24.09
  • PRTA $25.42
  • Technical
  • Relative Strength Index (RSI)
  • INVX N/A
  • PRTA 34.08
  • Support Level
  • INVX N/A
  • PRTA $12.46
  • Resistance Level
  • INVX N/A
  • PRTA $13.52
  • Average True Range (ATR)
  • INVX 0.00
  • PRTA 0.76
  • MACD
  • INVX 0.00
  • PRTA -0.13
  • Stochastic Oscillator
  • INVX 0.00
  • PRTA 10.96

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, and installs mission-critical drilling & deployment, well construction, completion, production, and fishing & intervention solutions to support upstream onshore and offshore activities worldwide. Its comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. With locations throughout North America, Latin America, Europe, the Middle East, and Asia, The team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Share on Social Networks: